Related Experiment Video
Updated: May 17, 2026

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
Published on: October 17, 2018
Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease
Jörn F Dopheide1, Viviane Obst, Christopher Doppler
1Department of Internal Medicine II, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany. dopheide@uni-mainz.de
Insights
Peripheral arterial disease (PAD) patients exhibit increased proinflammatory monocytes. However, critical limb ischemia (CLI) patients show reduced inflammatory markers on myeloid and plasmacytoid dendritic cells (mDCs and pDCs), suggesting a complex immune response in advanced PAD.
Area of Science:
- Immunology
- Vascular Biology
- Cellular Biology
Background:
- Atherosclerosis, a chronic inflammatory disease, involves monocytes and dendritic cells (DCs).
- Peripheral arterial disease (PAD) severity influences immune cell phenotypes.
Purpose of the Study:
- To phenotypically characterize monocytes, myeloid DCs (mDCs), and plasmacytoid DCs (pDCs) in patients with varying degrees of PAD.
- To investigate immune cell alterations in intermittent claudication (IC) versus critical limb ischemia (CLI).
Main Methods:
- Flow cytometry analysis of peripheral blood leukocytes from 60 PAD patients (30 IC, 30 CLI) and 30 controls.
- Gating strategies to identify and analyze monocytes, mDCs, and pDCs.
- Assessment of cell surface marker expression (e.g., CD14, CD16, HLA-DR, CD86, CD40).
Main Results:
- PAD patients displayed a higher proportion of proinflammatory CD14++CD16+ monocytes compared to controls.
- PAD patients showed increased mDCs and reduced pDCs, altering the mDC/pDC ratio.
- CLI patients exhibited reduced HLA-DR, CD86, and CD40 expression on both mDCs and pDCs compared to IC patients.
Conclusions:
- Peripheral blood monocytes adopt a proinflammatory phenotype in PAD.
- Critical limb ischemia (CLI) is associated with reduced expression of inflammatory markers on dendritic cells.
- Severe ischemia or prolonged inflammation in CLI may paradoxically attenuate mononuclear cell proinflammatory patterns, potentially impairing immune regulation and disease progression.
Abstract:
Atherosclerosis is a chronic inflammatory process involving antigen-presenting cells like monocytes and dendritic cells (DC). The aim of this study was to perform a phenotypic characterisation of these cell types in patients with different degrees of peripheral arterial disease (PAD). Sixty patients with PAD [N= 30 intermittent claudication (IC), N= 30 critical limb ischemia (CLI)] and 30 controls were included. Peripheral blood leucocytes were analysed from peripheral blood by flow cytometry using different gating strategies to directly identify and analyse monocytes, myeloid DC, (mDC) and plasmacytoid DC (pDC). PAD patients showed a significantly higher proportion of proinflammatory CD14++CD16+ monocytes (p<0.0001) compared with healthy individuals. We found an increased number of mDC/ml and a reduced number of pDC/ml (both p<0.01) in PAD patients, leading to a shift in the mDC/pDC ratio (p<0.01). As compared to patients with intermittent claudication, CLI patients presented a reduced expression of HLA-DR (p<0.01), CD86 and CD40 on both mDCs and pDCs (p<0.01). Peripheral blood monocytes show a proinflammatory phenotype in PAD patients compared to controls. In contrast, CLI patients show a reduced expression of proinflammatory markers. We hypothesise that severe ischaemia and/or prolonged inflammation in CLI might lead to a paradoxical attenuation in the proinflammatory membrane pattern of circulating mononuclear cells, possibly hindering an adequate regulatory function of mDCs and pDCs and favouring the progression of disease.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Inflammation
Coronary Artery Disease II: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Chronic Inflammation: Introduction

